SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021)
SOPHiA GENETICS's (SOPH) quarterly Raw Materials came in at $5.1 million in Q4 2021, up 57.17% year-on-year from $3.2 million in Q4 2020, and up 57.17% quarter-over-quarter from $3.2 million in Q4 2020.
SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has disclosed Raw Materials across 2 years of filings, most recently posting $5.1 million for Q4 2021.
- Raw Materials for Q4 2021 came in at $5.1 million, up 57.17% year-over-year; the trailing twelve-month figure through Dec 2021 was $5.1 million (up 57.17% YoY), and the FY2021 annual result was $5.1 million, up 57.17% from the prior year.
- Raw Materials came in at $5.1 million for Q4 2021 at SOPHiA GENETICS, up from $3.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $5.1 million in Q4 2021 to a low of $3.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | SOPHiA GENETICS | 26.19 Mn | -44.10 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.11 Mn |
| Dec 31, 2020 | 3.25 Mn |